Jerusalem Pharmaceuticals Co. Ltd.

PLSE:JPH Stock Report

Market Cap: US$64.4m

Jerusalem Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of JPH?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,070,5065.95%
Private Companies3,490,04719.4%
General Public5,831,94332.4%
Individual Insiders7,607,50442.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 16 shareholders own 67.6% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
29.8%
Mohammed Mahmoud Masrouji
5,369,666US$19.2m0%no data
18.3%
Masrouji For General Trading Company
3,294,838US$11.8m0%no data
5.95%
Palestinian Pension Agency
1,070,506US$3.8m0%no data
3.22%
Ibrahim Ali Al-Taweel
580,002US$2.1m0%no data
2.05%
Nidal Kamal
368,217US$1.3m0%no data
1.53%
Yusuf Amin
275,876US$987.6k0%no data
1.52%
Fouad Ahmed Al Absi
274,196US$981.6k0%no data
1.41%
Samir Sadeq Qaderi
253,472US$907.4k0%no data
1.08%
Mansour Book Shop & Printing Company
195,209US$698.8k0%no data
1.03%
Lina Masrouji
184,796US$661.6k0%no data
0.59%
Iyad Masrouji
106,157US$380.0k0%no data
0.38%
Darwish Assali
68,786US$246.3k0%no data
0.37%
Mohammad Al Amour
66,336US$237.5k0%no data
0.11%
Salim Al Haj Yahia
20,000US$71.6k0%no data
0.11%
Mohammed Samir Khatib
20,000US$71.6k0%no data
0.11%
Rafiq Haidar Al Husseini
20,000US$71.6k0%no data